Outlook Therapeutics Inc. (NASDAQ: OTLK)
$9.23
+0.7800 ( +9.23% ) 262.8K
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.
Market Data
Open
$9.23
Previous close
$8.45
Volume
262.8K
Market cap
$215.80M
Day range
$8.46 - $9.24
52 week range
$4.00 - $37.00
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 16 | Feb 14, 2024 |
| def | Proxies and info statements | 6 | Feb 08, 2024 |
| ars | Annual reports | 1 | Feb 08, 2024 |
| pre | Proxies and info statements | 6 | Jan 29, 2024 |
| 8-k | 8K-related | 22 | Jan 24, 2024 |
| 10-k/a | Quarterly Reports | 14 | Jan 24, 2024 |
| 10-k | Annual reports | 85 | Dec 22, 2023 |
| 8-k | 8K-related | 13 | Dec 22, 2023 |
| 8-k | 8K-related | 12 | Dec 06, 2023 |
| 8-k | 8K-related | 14 | Nov 02, 2023 |